secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001104659-24-073391
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood repays $200M convertible notes at maturity using cash and revolver; CFO adds COO role
--------------------------------------------------------------------------------

- Repaid $200M 0.75% Convertible Senior Notes due 2024 on June 17 using $50M cash and $150M from $500M revolver.
- Outstanding balance on $500M revolver increased to $425M following the $150M draw.
- Expects ~$100M cash and cash equivalents as of June 30, 2024 (preliminary estimate).
- Sravan K. Emany, current CFO, also appointed Chief Operating Officer effective immediately.
- Emany has been CFO since Dec 2021; no family relationships or transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465924073391/0001104659-24-073391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465924073391/tm2417654d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-073391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer